Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Report 2026

The specific immunoglobulin g subclass 4 (igg4) testing market size has grown rapidly in recent years. It will grow from $1.37 billion in 2025 to $1.54 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to increasing awareness of igg4-related diseases, expansion of diagnostic laboratory networks, growing use of antibody-based diagnostics, improvements in immunoassay technologies, rising clinical research activity.

The specific immunoglobulin g subclass 4 (igg4) testing market size is expected to see rapid growth in the next few years. It will grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, expansion of hospital-based testing facilities, growing investments in laboratory automation, rising adoption of advanced immunology panels, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of specialized immunoassays, rising demand for autoimmune disease diagnostics, growing use of igg4 testing in clinical practice, expansion of laboratory automation in immunology, enhanced focus on diagnostic accuracy.

The rising prevalence of allergic diseases is expected to drive the growth of the specific immunoglobulin G subclass 4 (IgG4) testing market in the coming years. Allergic diseases are immune-mediated hypersensitivity disorders such as food allergies, atopic dermatitis, asthma, and allergic rhinitis, which occur when the immune system reacts abnormally to normally harmless substances. The prevalence of these conditions is increasing due to changes in dietary patterns, as higher consumption of processed foods can alter gut microbiota and increase susceptibility to allergic sensitization. Specific IgG4 testing aids in assessing immune responses associated with repeated allergen exposure, helping clinicians understand tolerance patterns and interpret complex allergy-related immune activity. For instance, in May 2024, the UK Food Standards Agency reported that approximately 6%, or 2.4 million, of UK adults had a clinically confirmed food allergy. Therefore, the rising prevalence of allergic diseases is fueling the growth of the specific IgG4 testing market.

Major companies in the IgG4 testing market are focusing on innovations in testing platforms and methodologies, such as high-sensitivity immunoassay technology, to enhance assay accuracy, analytical performance, and diagnostic reliability. High-sensitivity immunoassays use optimized antibodies, enhanced signal-generation chemistries, and refined workflows to detect very low analyte concentrations with high precision, providing improved detection limits, superior specificity, and reproducible results. For example, in September 2025, Alta DiagnoTech, a US-based IVD immunoassay solutions provider, launched ELISA kits for immunology testing. These high-sensitivity kits enable accurate biomarker quantification across a wide range of immunological applications, offering enhanced assay sensitivity, strong manufacturing stability, and broad workflow applicability. This platform improves test reliability, analytical precision, and diagnostic confidence in immunology testing environments.

In December 2023, Danaher Corporation, a US-based provider of life sciences, diagnostics, and biotechnology solutions, acquired Abcam plc for $5.7 billion. This acquisition allowed Danaher to gain access to Abcam’s extensive portfolio of antibodies, recombinant proteins, assay kits, and immunoassay reagents, strengthening its specialized immunodiagnostic capabilities, including those for IgG4 testing workflows. Abcam plc, a UK-based provider of high-quality biological reagents and research assay solutions, is renowned for its expertise in antibody development and standardized ELISA platforms, including research-grade IgG4-specific tools widely used in immunology and biomarker studies.

Major companies operating in the specific immunoglobulin g subclass 4 (igg4) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Revvity, Randox Laboratories Ltd, NeoGenomics Laboratories Inc., ARUP Laboratories, Dr Lal PathLabs Limited, Metropolis Healthcare Ltd, ProSci Incorporated, Leinco Technologies Incorporated, MyBioSource Inc., Boster Biological Technology, PROTIA Inc., Creative Diagnostics LLC.

North America was the largest region in the specific immunoglobulin G subclass 4 (IgG4) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specific immunoglobulin g subclass 4 (igg4) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the specific immunoglobulin g subclass 4 (igg4) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are affecting the specific igg4 testing market by increasing costs of imported reagents, assay kits, automated analyzers, and laboratory consumables used in immunological testing. Diagnostic laboratories and hospitals in North America and Europe are most impacted due to reliance on imported high-quality testing kits, while Asia-Pacific faces higher costs for analyzer manufacturing and exports. These tariffs are increasing per-test costs and affecting laboratory margins. However, they are also encouraging local reagent manufacturing, regional kit production, and domestic diagnostic innovation.

The specific immunoglobulin g subclass 4 (igg4) testing market research report is one of a series of new reports that provides specific immunoglobulin g subclass 4 (igg4) testing market statistics, including specific immunoglobulin g subclass 4 (igg4) testing industry global market size, regional shares, competitors with a specific immunoglobulin g subclass 4 (igg4) testing market share, detailed specific immunoglobulin g subclass 4 (igg4) testing market segments, market trends and opportunities, and any further data you may need to thrive in the specific immunoglobulin g subclass 4 (igg4) testing industry. This specific immunoglobulin g subclass 4 (igg4) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Specific immunoglobulin G subclass 4 (IgG4) testing measures the level of IgG4, an antibody produced by the body as part of its immune response. The test analyzes a blood sample to determine IgG4 concentration, as elevated levels may indicate abnormal immune activity. Results assist clinicians in evaluating conditions such as IgG4-related disease and in understanding certain immune or inflammatory responses.

The main product types of specific IgG4 testing include reagents and kits, instruments, and services. Reagents and kits are pre-packaged chemical or biological materials designed to enable accurate detection, measurement, or analysis of specific targets in diagnostic testing. Key applications include allergy diagnosis, autoimmune disease evaluation, research, and others, serving end users such as hospitals and clinics, diagnostic laboratories, research institutes, and more.

The specific immunoglobulin G subclass 4 (IgG4) testing market includes revenues earned by entities by providing services such as sample collection services, specimen transport services, pre-analytical preparation services, data management services, clinical consultation services, and results dissemination services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.